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Cadaver versus living donor kidneys: Impact of donor factors uals who are genetically related to the recipient, whereas
on antigen induction before transplantation. cadaver donor kidneys may undergo abnormal physio-
Background. It is widely recognized that living-related do- logical changes associated with brain death, may experi-nor (LRD) renal allografts have a higher overall graft survival
ence prolonged cold storage times, and may be trans-than cadaver donor transplants. We tested the hypothesis that
planted into unrelated recipients. In living-unrelated donorpart of this is attributable to LRD kidneys being obtained under
optimal conditions from healthy donors, whereas cadaveric (LURD) transplantation, the immunological barriers are
kidneys may have experienced injury as a result of inflamma- similar to those encountered with cadaveric allografts,
tory events around the time of brain death. but the clinical outcome of LURD allografts is signifi-Methods. We have performed a comparative immunohisto-
cantly better than that of cadaveric transplantation andchemical analysis of pretransplant donor biopsies from cadav-
similar to one haplotype disparate LRD transplants [3–9].eric (N 5 65) and LRD (N 5 29) kidneys to determine any
differences that may predispose them to subsequent damage. The high success rates of LURD transplantation prob-
Cryostat sections were stained with antibodies to leukocytes, ably reflects the use of organs obtained under optimal
adhesion molecules, and human leukocyte antigen (HLA)-DR
conditions, as there is little genetic advantage over cadav-antigens, and the expression was assessed semiquantitatively.
eric transplantation. Furthermore, we have previouslyResults. High levels of endothelial E-selectin and proximal
tubular expression of HLA-DR antigens, intercellular adhesion demonstrated that immediately following transplanta-
molecule-1, and vascular cell adhesion molecule-1 were detected tion, cadaver renal allografts may experience a nonspe-
in biopsies from cadaveric kidneys, whereas expression of these cific inflammatory response associated with prolonged
markers was markedly reduced in LRD kidneys. High levels
cold ischemia and reperfusion injury [10]. It is possibleof tubular antigen expression were significantly associated with
that early damage to cadaveric organs may render themtraumatic death, prolonged ventilation, and episodes of infec-
tion in cadaver donors. Furthermore, the expression of pretrans- more susceptible to harmful physiological and immuno-
plant tubular antigens in cadaver donor kidneys was significantly logical events following transplantation.
associated with early acute rejection following transplantation, The effects of the host immune response against thesuggesting that such kidneys are predisposed to subsequent
allograft have been studied by analyzing post-transplantimmune-mediated attack following transplantation.
biopsies. During episodes of acute rejection, leukocyteConclusions. These results may explain, in part, the superior
outcome of LRD allografts compared with cadaver renal allo- infiltration is detected in association with up-regulated
grafts. expression of adhesion molecules and human leukocyte
antigen (HLA) class II antigens [reviewed in 11]. Inter-
estingly, several studies have shown that varying levels
In clinical renal transplantation, allografts from living- of expression of these molecules may be detected in
related donors (LRD) have superior graft function and biopsies from cadaver donor kidneys before transplanta-
survival compared with cadaver allografts [1–3]. LRD kid- tion [12–18]. However, only a few pretransplant biopsies
neys are obtained from carefully screened, healthy individ- were analyzed, thus precluding the meaningful analysis
of possible donor-derived factors that may be involved
in the induction of antigen expression. The presence ofKey words: adhesion molecules, rejection, renal transplantation, ca-
daver organ donors, allografts. high levels of adhesion molecules in the donor kidneys
before transplantation provides a mechanism for leuko-Received for publication January 15, 1999
cyte recruitment into the graft and initiation of an alloim-and in revised form April 23, 1999
Accepted for publication April 29, 1999 mune response.
In this study, we compared the expression of adhesion 1999 by the International Society of Nephrology
1551
Koo et al: Cadaver versus LRD kidneys1552
Table 1. Demographics of donor and clinical parameters following Monoclonal antibodies and immunohistochemistry
renal transplantation
Seven-micrometer cryostat sections from wedge biop-
Cadaver LRD sies were stained using an indirect immunoperoxidaseClinical parameters (N 5 65) (N 529)
technique as previously described [12]. The sections were
Donor sex (M:F) 33:32 7:22 stained with monoclonal antibodies, 5D11 (anti–E-Donor age years 6 sd 40614.7 43 610
selectin), 4B2 [anti–vascular cell adhesion molecule-1Trauma at deatha 22/65 N/A
Ventilator support days 6 sd 2.1761.45 N/A (VCAM-1)], 14C11 [anti–intercellular adhesion mole-
Episode of cardiac arrest 12/65 N/A cule-1 (ICAM-1)], which were all obtained from BritishInotropic support 42/65 N/A
Biotechnology Ltd. (Oxford, UK), Cyto-DR (HLA-DR;Desmopressin (DDAVP) treatment 18/65 N/A
Donor infection 17/65 N/A Coulter Immunology, Hialeah, FL, USA), F10.89.4 (anti-
Urine output (final hour) ml 6 sd 1946197 N/A CD45 leukocyte common marker) [20], UCHT-1 (anti-
Rate of urine output ml/hr 6 sd 1836110 N/A
CD3 T-cell marker) [21], UCHM-1 (anti-CD14 monocyte/Blood urea mmol /liter 6 sd 5.962.7 N/A
Donor serum creatinine lmol liter 6 sd 94638 N/A macrophage marker) [22], EBM/11 (anti-CD68 mono-
Donor blood transfusion 16/65 N/A cyte/macrophage marker) [23], antineutrophil elastase
Local vs. shipped kidney (L:S) 48:17 N/A
(Dako Ltd., High Wycombe, Bucks, UK) and G1 (anti–Multi/single organ donor (M:S) 56:9 N/A
Cold ischemia timeb hours 6 sd 25.1610.0 1.9 60.5 P-selectin) [24]. Detection of E- and P-selectin was en-
Delayed graft functionc 10/65 6/29 hanced by an additional incubation step with a peroxi-
Serum creatinine (3 months) lmol /liter 6 sd 153651 141 637 dase-conjugated swine antirabbit Ig (Dako Ltd.), whichSerum creatinine (6 months) lmol /liter 6 sd 154648 140 629
was preblocked with human AB serum.No. of rejection episodes (0:1:2:3)d 30:22:6:7 12:12:5:0
Rejection by day 7 post-transplantation 11/65 5/29
Assessment of staininga Traumatic death was defined by the Donating Centre as death resulting from
road traffic accidents or other forms of severe physical injury Semiquantitative staining was scored by two indepen-b Significant difference between LRD and cadaver donors (P , 0.01)
c Delayed graft function was defined as the requirement for dialysis in the first dent observers (S.V.F. and D.D.H.K.) without prior
week after transplantation knowledge of the clinical information. Leukocyte infil-d Acute rejection was defined as an elevation of serum creatinine (.15%
tration was analyzed with respect to localization in (a)above baseline and a response to anti-rejection therapy (98% biopsy proven)
the glomeruli (mean number of positive cells per glomer-
ulus per section) and (b) intertubular areas (mean leuko-
cyte number per field of view; 310 objective). The semi-
molecules and HLA class II antigens in LRD and ca- quantitative grades given for the endothelial expression
daver donor kidneys prior to transplantation and related of E- and P-selectin were scored as previously described
the levels of expression to donor parameters. Further- [10]: 0 5 negative; 1 5 negative with an isolated positive
more, we investigated whether high levels of antigen vessel; 2 5 focus of positive vessels or occasional positive
vessels throughout the biopsy; 3 5 multiple foci or aexpression in kidneys before transplantation were sig-
single focus with positive vessels distributed throughoutnificantly associated with subsequent post-transplant re-
the biopsy. The semiquantitative grading for ICAM-1,jection or impaired graft function.
VCAM-1, and HLA-DR antigens was based on proximal
tubular expression and was scored as grade 0, negative
METHODS or weakly positive, and grade 1, strongly positive.
Patients and biopsy material
Statistical analyses
An immunohistochemical analysis was performed on
Univariate analysis using Student’s t-test, Fisher’s ex-renal biopsies obtained from two groups of renal trans-
act test, and x2 tests was performed to analyze the resultsplant donors: (a) cadaveric donors (N 5 65) and (b)
of the immunohistological staining with respect to clini-LRDs (N 5 29). Pretransplant wedge biopsies were ob-
cal parameters. In view of the large number of compari-tained from kidneys after perfusion and cold storage with
sons, multiple logistic regression using the SPSS Statisti-
hypertonic citrate (Marshall’s) solution. As controls, five cal Program (version 8.0) was performed to determine
biopsies were obtained from cadaver donor kidneys at whether significant univariate associations between ele-
the time of organ retrieval, prior to cold perfusion and vated antigen expression and possible predictive donor
storage. Standard triple-therapy immunosuppression (cy- parameters were identified through chance events.
closporine, azathioprine, and steroids) was administered
to all transplant recipients [19]. Relevant donor and clini-
RESULTScal parameters for cadaver and LRDs are listed in Table
Immunohistological differences between cadaver and1. Donor data were obtained from kidney donor informa-
living-related donor kidneystion forms completed by the donating centers and recipi-
ent surgeons and were supplied by the United Kingdom Leukocyte markers. No significant differences were
observed in the level of leukocyte infiltration betweenTransplant Support Service Authority (UKTSSA).
Koo et al: Cadaver versus LRD kidneys 1553
cadaveric and LRD kidneys. CD31 T cells were absent
in the majority of donor kidneys, but in occasional biops-
ies, isolated cells were detected in the interstitium. Both
cadaveric and LRD kidneys had high numbers of resi-
dent macrophages, with no differences between the two
donor groups. In 7 out of 65 (11%) cadaver donor kid-
neys, a large number of neutrophils were detected in
the glomeruli and intertubular areas, but there was no
statistically significant difference compared with LRD
kidneys.
Endothelial adhesion molecules. Low levels of P-selec-
tin expression were detected on isolated intertubular capil-
laries in wedge biopsies obtained from both cadaveric
and LRD kidneys, with no significant differences in the
percentage of kidneys with high levels ($grade 2) of
P-selectin expression (Fig. 1a). In marked contrast, sig-
nificantly higher levels of intertubular capillary E-selectin
expression ($grade 2) were detected in 35 out of 65
(54%) cadaver donor kidneys compared with LRD kid-
neys, none of which expressed E-selectin (P , 0.00001;
Figs. 1b and 2 a, b).
Proximal tubular expression of intercellular adhesion
molecule-1, vascular cell adhesion molecule-1, and human
leukocyte antigen-DR antigens. Biopsies from cadaveric
and LRD kidneys were examined for differences in ex-
pression of ICAM-1, VCAM-1, and HLA-DR antigens
on the proximal tubules. Constitutive expression of
HLA-DR antigens was detected on glomerular endothe-
lium and mesangium, intertubular capillaries, and inter-
stitial leukocytes, as previously reported [13]. However,
variable levels of HLA-DR antigens were detected in
the cytoplasm and on the membranes of proximal tu-
bules, with strong HLA-DR antigen expression (grade 1)
in 43 out of 65 (66%) cadaver donor kidneys, whereas
only 2 out of 29 (7%) LRD kidneys were positive for
HLA-DR antigens (P , 0.00001; Figs. 2 c, d and 3).
ICAM-1 expression was detected constitutively at high
levels on all vascular endothelium in both the LRD and
cadaver donor kidneys. High levels of proximal tubular
ICAM-1 expression (grade 1) were detected in 40 out
of 65 (62%) cadaver donor kidneys, whereas none of Fig. 1. Levels of P- and E-selectin expression in cadaveric and living-
the 29 LRD kidneys expressed tubular ICAM-1 (P , related donor (LRD) kidneys. (A) Similar patterns of low level P-selectin
expression were detected in cadaveric ( ; N 5 65) and LRD (h; N 50.00001; Figs. 2 e, f, and 3). Similarly, constitutive expres-
29) kidneys. (B) High levels of E-selectin expression ($ grade 2) weresion of VCAM-1 was detected on the Bowman’s capsule detected in 54% of cadaveric kidneys, whereas minimal expression was
of all the biopsies analyzed, but in 30 out of 65 (46%) observed in LRD kidneys.
cadaver donor kidneys, high levels of proximal tubular
VCAM-1 were detected, whereas all of the 29 LRD
kidneys were negative for tubular VCAM-1 (P , 0.00001; sion (defined as elevated levels of ICAM-1, VCAM-1,
Figs. 2 g, h, and 3). or HLA-DR antigens either alone or in combination) was
Analysis of associations between pairs of adhesion detected in 50 out of 65 (77%) cadaver kidneys (Fig. 3). No
molecule markers (using a x2 test with Yates’ correction) significant associations were observed between elevated
showed significant associations between high levels of tubular antigen expression and high levels of E-selectin
expression of the three tubular markers studied, with expression on the endothelium. There was also no sig-
the strongest associations between HLA-DR and other nificant association between neutrophil infiltration and
elevated E-selectin or tubular antigen expression.markers (P , 0.0001). Elevated tubular antigen expres-
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Table 2. Summary of statistically significant correlations between
clinical parameters and high levels of endothelial E-selectin
expression or induced tubular antigen expression in
cadaveric kidneys
Endothelial Tubular
Clinical parameters E-selectin antigen
Trauma at death NS P,0.05
Ventilator support .3 days NS P,0.05
Desmopressin (DDAVP) treatment P50.015 NS
Donor infection NS P,0.05
Rejection by day 7 post-transplantation NS P,0.05
Statistical analyses were performed using Fisher’s exact or Student’s t-test,
and confirmed by multiple logistic regression analysis with respect to the large
number of comparisons performed. NS is not significant.
Fig. 3. Expression of HLA-DR antigens, intercellular adhesion molec- endothelial E-selectin (x2 5 32.46, P 5 0.0087) and tubu-
ular-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) on
lar antigen induction (x2 5 27.37, P 5 0.0375). Thethe proximal tubules of cadaveric (j; N 5 65) and living-related donor
Hosmer-Lemeshow x2 test suggested that this model was(LRD; h; N 5 29) kidneys. High levels of HLA-DR antigens were
detected on the proximal tubules of 66% of cadaveric kidneys, whereas a reasonable fit. This analysis suggests that the significant
only 7% of LRD kidneys had elevated HLA-DR antigen expression
univariate associations did not arise through chance be-(P , 0.00001). Elevated ICAM-1 and VCAM-1 expression was detected
cause of the number of factors tested.in 62 and 48% of cadaveric kidneys, respectively, whereas all 29 LRD
kidneys were negative for tubular ICAM-1 and VCAM-1 expression
(P , 0.00001). Elevated tubular antigen expression, defined as expres- Donor parameters
sion of either HLA-DR antigens, ICAM-1 or VCAM-1 either alone or
No significant associations were observed betweenin combination, was detected in 50 out of 65 (77%) cadaver kidneys,
whereas only 2 out of 29 (7%) LRD kidneys had induced tubular high levels of adhesion molecule and HLA-DR antigen
antigen expression (P , 0.00001).
expression with donor age, sex, HLA type, local or
shipped kidneys, multi/single organ donors, and cold is-
chemia time. However, elevated expression of proximal
tubular antigens was detected in 20 out of 22 (91%)Organ retrieval biopsies. No differences in adhesion
molecule and HLA-DR antigen expression were de- kidneys from cadaver donors who suffered a traumatic
death, whereas it was present in only 30 out of 43 (70%)tected between biopsies obtained at the time of organ
retrieval and subsequent pretransplant biopsies from the of cadaver donors who experienced nontraumatic death
(P , 0.05).same kidneys taken after cold storage. That is, in cases
in which expression of these molecules was up-regulated
Clinical events in the intensive care unitin kidneys at the time of organ retrieval, the appearance
was subsequently unchanged following cold storage. In all 15 cadaver donor kidneys with no tubular antigen
induction, the period of ventilator support was approxi-Associations of adhesion molecule and human leuko-
cyte antigen-DR expression with clinical parameters. The mately three days, whereas in 11 out of 50 cadaver kid-
neys with induced tubular antigen expression, the periodexpression of high levels of endothelial and tubular anti-
gens in a large proportion of cadaver donor kidneys of ventilator support was more than three days (P 5
0.041). Furthermore, in 16 out of 17 (94%) of donorswas analyzed with respect to relevant donor and clinical
parameters (Table 1). Statistically significant univariate with a recorded incidence of infection, there were ele-
vated levels of proximal tubular antigens, although in 34correlations between clinical parameters listed in Table
1 and elevated expression of endothelial E-selectin or out of 58 (59%) of donors with no infection, tubular
antigens were also detected (P , 0.05). The mean periodtubular antigens are summarized in Table 2. Multiple
logistic regression analysis demonstrated that there was of ventilation for donors with infection episodes (3.18 6
2.0 days) was significantly greater than those with noan overall effect of these donor factors on expression of
b
Fig. 2. Immunohistological differences in adhesion molecule and HLA-DR antigen expression between cadaveric and living-related donor (LRD)
kidneys. All biopsies were stained using monoclonal antibodies and were developed by an indirect immunoperoxidase method. (a) LRD kidney
stained with an anti–E-selectin antibody demonstrating negative expression and (b) a cadaveric kidney with high levels of E-selectin on the intertubular
capillaries. (c) LRD kidney with negative tubular expression of HLA-DR antigens and (d) a cadaveric kidney with strong expression of HLA-DR
antigens on the proximal tubules. (e) Intercellular adhesion molecular-1 (ICAM-1) was absent on the proximal tubules of all LRD kidneys, whereas
( f ) tubular ICAM-1 was detected at high levels in a proportion of cadaveric kidneys. (g) Similarly, all LRD kidneys were negative for expression
of tubular vascular cell adhesion molecule-1 (VCAM-1), whereas (h) a proportion of cadaveric kidneys had high levels of tubular VCAM-1.
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with a biopsy-confirmed acute rejection episode within
seven days of transplantation. In contrast, tubular anti-
gens were absent in 15 out of 54 (28%) donor kidneys
with no rejection in the first seven days (P , 0.05).
There were no significant associations with delayed graft
function, number of rejection episodes, and three- and
six-month serum creatinine levels.
DISCUSSION
The superior graft survival of living donor kidney
transplantation compared with cadaver transplantation
is partly attributable to the procurement of organs under
optimal conditions from healthy donors with minimal
ischemia times. In contrast, cadaver donor kidneys expe-
rience prolonged periods of cold storage and may un-
dergo traumatic events associated with intensive care
management, cause of death, and the abnormal physio-
logical states associated with brain death. The results
Fig. 4. Relationship between ventilation time, induced tubular antigen from this immunohistochemical study demonstrate a
expression, and episodes of infection in cadaver donors. The mean striking difference in adhesion molecule and HLA-DRperiod of ventilator support for cadaver donors with induced tubular
antigen expression between cadaveric and LRD kidneysantigen expression (2.4 6 1.5 days; h) was higher than that of donors
with no tubular antigen induction (1.6 6 0.9 days; s). Donors with an before transplantation.
episode of infection were also identified with respect to induced tubular High levels of E-selectin expression were detected onantigen expression (j) or no tubular antigen induction (d).
the intertubular capillaries of a large proportion of ca-
daver donor kidneys, whereas E-selectin expression was
absent in all 29 LRD kidneys (P , 0.00001). Maximal
infection (1.83 6 1.0 days, P , 0.01). The relationship
E-selectin expression was observed four to six hours
between prolonged ventilation, tubular antigen expres-
following cytokine stimulation of endothelial cells, re-
sion, and donor infection is illustrated in Figure 4. There
turning to basal levels after 24 hours [25]. E-selectin was
were no significant associations between high levels of
involved in the initial recruitment of leukocytes to anadhesion molecules or HLA-DR antigen expression and
inflammatory site [26–28] and was up-regulated duringdonor blood transfusions or episodes of cardiac arrest
allograft rejection [17, 29, 30]. Indeed, we demonstratedin the donors.
that E-selectin expression detected before transplantation
is maintained immediately following reperfusion of ca-Drug administration
daver renal allografts [10] and thus may facilitate leuko-There was a significant association between high levels
cyte-mediated cell damage. Elevated levels of proximalof E-selectin expression and the administration of desmo-
tubular ICAM-1 and VCAM-1 were detected in a pro-pressin [(1-desamino-8-d-arginine vasopressin (DDAVP)]
portion of cadaver donor kidneys, whereas all LRD kid-to the donor prior to organ retrieval. In 14 out of 18
neys were negative for tubular adhesion molecule ex-(78%) donors who received DDAVP, there were high
pression (P , 0.00001). ICAM-1 and VCAM-1 have beenlevels of E-selectin expression, whereas E-selectin ex-
shown to be up-regulated on proximal tubules during renalpression was only detected in 21 out of 47 (45%) donors
allograft rejection [14, 17, 18, 29, 31]. Cytokine stimulationwho did not receive DDAVP (P 5 0.015). No significant
of cultured renal tubular epithelial cells demonstrated thatassociations were observed between the administration
ICAM-1 and VCAM-1 expression peaks between oneof inotropes and elevated levels of endothelial or tubular
and two days [32, 33], a greater period than requiredadhesion molecule or HLA-DR antigen expression.
for endothelial E-selectin expression. This difference in
Donor renal function kinetic profiles may explain why no significant associa-
tions were found between endothelial E-selectin and tu-No significant associations were observed with the rate
bular adhesion molecule expression.of urine output, volume of urine produced in the final
The recruitment of leukocytes by endothelial adhesionhour, serum creatinine, or urea levels.
molecules has been well characterized [11, 34], but the
Post-transplantation events role of tubular adhesion molecule expression is less
clearly defined. In vitro data have demonstrated thatElevated tubular antigen expression was evident be-
fore transplantation in all 11 cadaver renal allografts renal tubular epithelial cells with induced ICAM-1 and
Koo et al: Cadaver versus LRD kidneys 1557
VCAM-1 expression are capable of binding lymphocytes tion of plasma lactate, and reduced oxygen availability
to the organs [38, 39].[32, 33, 35]. The induction of tubular adhesion molecule
The secondary effects of brain damage may result inexpression may facilitate the infiltration of T lymphocytes
markedly reduced production of vasopressin, leading tointo the tubules, resulting in tubulitis, a pathophysiologi-
diabetes insipidus and loss of homeostatic regulation.cal event associated with allograft rejection. HLA-DR
Excessive diuresis is controlled with the administrationantigens were also detected on the proximal tubules of
of the l-arginine vasopressin analogue, DDAVP, a pow-cadaver donor kidneys, and up-regulated expression was
erful antidiuretic [40]. The administration of DDAVPsignificantly associated with elevated tubular ICAM-1
to cadaver donors has proven to be controversial withand VCAM-1 expression (P , 0.0001). This supports in
respect to subsequent renal allograft outcome [41, 42].vitro studies that have shown that tubular HLA class II
Our results have demonstrated that a significant numberexpression has similar kinetics to tubular ICAM-1 and
of cadaveric donors receiving DDAVP treatment hadVCAM-1 expression [35]. It may be surprising that high
elevated levels of E-selectin expression on the intertubu-levels of adhesion molecule expression were detected in
lar capillaries. DDAVP has additional properties thatthe absence of increased levels of leukocyte infiltration,
enable its use for the treatment of bleeding disordersbut little is known with respect to immune regulation
[43, 44] but may result in cellular damage within a donorfollowing brain death. It is probable that following trau-
organ, as in vitro data demonstrate that DDAVP stimu-matic events in the donor (for example, severe physical
lates platelet and endothelial P-selectin expression andinjury, infection, brain death), there may be systemic
increased platelet-activating factor levels on monocytesrelease of cytokines into the circulation, resulting in ele-
[45–47]. Therefore, controlling excessive diuresis withvated adhesion molecule expression in peripheral organs
DDAVP may result in secondary effects on hemostasisbut no specific site-directed leukocyte infiltration as de-
and endothelial activation.tected during allograft rejection or infection. However,
Elevated proximal tubular antigen expression was sig-the expression of tubular VCAM-1, ICAM-1, and HLA
nificantly associated with prolonged ventilator supportclass II antigens in cadaver donor kidneys may render
of cadaver donors. It is widely recognized that patientsrenal allografts more susceptible to cell-mediated attack
on prolonged ventilation are susceptible to respiratoryfollowing transplantation. Indeed, in all 11 cadaver renal
tract infections; therefore, unsurprisingly, significant as-allografts with a rejection episode by day 7 post-transplant,
sociations were detected between elevated tubular anti-high levels of tubular antigen expression were detected
gen expression and recorded incidences of infection. Ourpretransplant (P , 0.05).
results suggest that the increased risk of infection as aA comparison of biopsies obtained from five cadaver
result of prolonged ventilation in the potential organ do-
kidneys before and after cold storage demonstrated that
nor may increase the likelihood of systemic inflammatory
antigen expression was detected at the time of organ events affecting peripheral organs. Another possible ex-
procurement and was not elevated following cold ische- planation may be that patients requiring ventilator sup-
mia. These results suggest that inflammatory responses port are close to brain death. The physiological effects of
occur in cadaver donors, probably several hours or days brain death on neurological and hormonal functions are
before organ procurement, enabling a sufficient period well defined, but little is known about the immunological
for transcription and expression of adhesion molecule events associated with brain death [reviewed in 48].
and HLA-DR antigens. In experimental models of trans- However, recent evidence from a rat model of acutely
plantation, induced antigen expression is not detected induced brain death demonstrated increased expression
in donor organs because they are procured from healthy, of adhesion molecules, multiple histocompatibility com-
anesthetized animals that do not experience brain death, plex antigens, inflammatory cytokines, and costimulatory
a situation similar to that in human LRD transplantation. molecules in peripheral organs up to six hours following
One of the major differences between living and cadav- brain death [49]. Furthermore, dramatic increases in
eric donors is that physiological abnormalities may occur interleukin-6 and severe hormonal imbalances have been
prior to the procurement of cadaver donor organs. Cadav- detected in blood obtained from patients at the moment
eric donors require careful management of cardiovascular, of diagnosis of brain death [50]. The results from these
pulmonary, and homeostatic functions in intensive care, studies may explain, in part, the high levels of adhesion
but if stability of vital functions is not maintained, ad- molecule and HLA-DR antigen expression in cadaver
verse alterations in renal blood flow may result. Animal donor kidneys and not in LRD kidneys. Moreover, we
studies have demonstrated that reduction of blood flow have shown that cadaveric donors who suffered a trau-
to peripheral organs following brain death may result in matic death as a result of road traffic accidents or severe
ischemic damage [36, 37]. This may be further exacer- physical injury were found to have a significantly higher
bated by abnormal rates of oxygen consumption and incidence of tubular antigen expression. Victims of trau-
matic death may have experienced systemic release ofdelivery, leading to anaerobic metabolism, an accumula-
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